Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
暂无分享,去创建一个
M. Overman | W. Nelson | P. A. Campbell | G. L. David-Beabes | J. Petrofski | A. De Marzo | A. M. De Marzo | P. Campbell | A. D. De Marzo | G L David-Beabes | M J Overman | J A Petrofski | P A Campbell | W G Nelson